Latest News

Source:
Date range from to
Keyword:

Researchers reveal how certain nerves sustain prostate cancer growth

News Medical (Australia) - 20/10/2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate.

Study shows how nerves drive prostate cancer

Science Daily (US) - 19/10/2017
Certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate, show researchers. Their earlier research -- which first implicated nerves in fueling prostate cancer -- has prompted a pilot study testing whether beta blockers (commonly used for treating hypertension) can kill cancer cells in tumors of men diagnosed with prostate cancer.

Common hair loss drug could slash risk of prostate cancer

Daily Mail (UK) - 13/10/2017
EXCLUSIVE: South Korean scientists discovered men taking the male pattern baldness drug finasteride, used by US President Donald Trump, slashed their PSA levels by a third.

New biomarker predicts metastatic prostate cancers

Science Daily (US) - 09/10/2017
Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are prone to becoming aggressive and spreading beyond the prostate, making them difficult to treat and life-threatening. Currently, doctors have limited ability to predict which newly diagnosed tumors will progress slowly and which will probably undergo dangerous spread.

One in four NHS prostate cancer units shut

Daily Mail (UK) - 04/10/2017
The NHS centres lost patients to richer, bigger hospitals able to buy the £1.5million machines - but researchers have warned there is no evidence the robots are better than surgeons.

New targeted alpha therapy protocol for advanced prostate cancer

Science Daily (US) - 03/10/2017
Therapy options are limited for men with advanced-stage, metastatic castration-resistant prostate cancer, but a new treatment protocol offers hope. Researchers report on their novel dosing regimen for actinium-225-labeled targeted alpha therapy of patients with prostate specific membrane antigen (PSMA)-positive tumors. The protocol balances treatment response with toxicity concerns to provide the most effective therapy with the least side effects.

Health Tip: Recognizing Prostate Cancer

MedicineNet (US) - 30/09/2017
Title: Health Tip: Recognizing Prostate CancerCategory: Health NewsCreated: 9/29/2017 12:00:00 AMLast Editorial Review: 9/29/2017 12:00:00 AM

High-precision radiotherapy for prostate cancer 'shows promise'

NHS Choices (UK) - 26/09/2017
"Targeted radiotherapy 'cures' prostate cancer that kills thousands," reports The Times. The news is based on a UK study of the use of high-precision radiotherapy to treat men with advanced localised prostate cancer. Researchers wanted to see if they could safely target cancer cells that had spread outside the prostate to nearby lymph nodes without damaging nearby healthy cells, and reduce treatment side effects. Prostate cancer is the most common cancer in men – more than 47,000 cases are diagnosed in the UK every year.

High-precision radiotherapy for prostate cancer 'shows promise'

Behind the Headlines (NHS, UK) - 26/09/2017
"Targeted radiotherapy 'cures' prostate cancer that kills thousands," reports The Times. The news is based on a UK study of the use of high-precision radiotherapy to treat men with advanced localised prostate cancer. Researchers wanted to see if they could safely target cancer cells that had spread outside the prostate to nearby lymph nodes without damaging nearby healthy cells, and reduce treatment side effects. Prostate cancer is the most common cancer in men – more than 47,000 cases are diagnosed in the UK every year.

3 in 4 terminal prostate cases 'cured by new radiotherapy'

Daily Mail (UK) - 26/09/2017
Researchers said 71 per cent of men with the disease were free of it five years after treatment. They believe the technique could benefit thousands of patients every year if it was available on the NHS.

UTSA professor awarded grant to support development of prostate cancer detection method

News Medical (Australia) - 25/09/2017
Jing Yong Ye, professor of biomedical engineering at The University of Texas at San Antonio (UTSA), has received a two-year, $354,617 grant from the National Institutes of Health's National Cancer Institute to support the development of his noninvasive method of detecting prostate cancer.

Common asthma drug could stop prostate cancer spreading  

Daily Mail (UK) - 24/09/2017
Once prostate cancer has formed tumour outposts in bone marrow, the disease is usually considered incurable. But scientists at the University of York discovered a drug could stop it spreading.

Prostate Cancer Symptoms Aren't Always Obvious

MedicineNet (US) - 22/09/2017
Title: Prostate Cancer Symptoms Aren't Always ObviousCategory: Health NewsCreated: 9/20/2017 12:00:00 AMLast Editorial Review: 9/21/2017 12:00:00 AM

Multiparametric MRI in prostate cancer

Cancerworld (EU) - 18/09/2017
This egrandround was first presented by Caroline Moore, from University College Hospital London, as a live webcast for the European School of Oncology. It is edited by Susan Mayor. The webcast of this and other e-grandrounds can be accessed at e-eso.net Until the last few years MRI was used essentially as a staging tool in prostate cancer, with imaging being performed after a biopsy to assess a patient’s suitability for radical treatment and for assessing extraprostatic extension and disease.

Fusion guided biopsy can help with accurate diagnosis of prostate cancer

News Medical (Australia) - 14/09/2017
There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It's called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.

Two new treatments may benefit patients with high risk prostate cancer, trial shows

News Medical (Australia) - 09/09/2017
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new treatments, according to late-breaking results from the STAMPEDE trial presented at the ESMO 2017 Congress in Madrid.

Prostate Cancer UK says GPs are ignoring black men

Daily Mail (UK) - 06/09/2017
Prostate Cancer UK said such patients are 'slipping through the net' because of the strain placed on GPs in the cash-strapped NHS. It made the claims on the back of a survey of 402 doctors (stock)

Breast cancer drug free on NHS 'treats prostate too'

Daily Mail (UK) - 05/09/2017
An inhibitor used to treat breast cancer could also be used to stop prostate cancer in men by preventing it from returning once the tumour has removed, a Surrey University study suggests.

New research could reduce recurrence of prostate cancer

News Medical (Australia) - 05/09/2017
Ground breaking research could reduce the recurrence of prostate cancer in males, a new study in the journal Nature Communications reports.

PSA screening significantly reduces the risk for death from prostate cancer

Science Daily (US) - 04/09/2017
After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality.